Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorRegina Elena Cancer Institute
About this trial
Evaluation of the percentage of transfusions in patients with breast cancer undergoing surgery after preventive treatment with haematinics.
Eligibility criteria
Qualifiers
age > 18 years;
patients diagnosed with histologically confirmed breast cancer and whether or not they have undergone neoadjuvant chemotherapy;
patients who are candidates for destructive and reconstructive breast surgery or not;
Hb values less than or equal to 11 g/dL and/or transferrin saturation less than or equal to 20%;
Disqualifiers
patients with known allergies to ferric carboxymaltose or its excipients;
ferritin values greater than 500 ng/ml;
patients unable to sign consent and comply with procedures.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
78 Participants
are grouped into 1 trial groupSponsors and collaborators
Regina Elena Cancer Institute
Lead sponsor
Campus Bio-Medico University
Collaborator
Umberto I Hospital, Frosinone Italy
Collaborator
Source ClinicalTrials.gov